BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home » Newsletters » BioWorld

BioWorld

June 4, 2018

View Archived Issues

Biotech money raised by month in 2018

Read More

Public financing of biotechnology companies: Commenced trading in May 2018

Read More

Public financing of biotechnology companies: Filed and pending IPOs in May 2018

Read More

Other financings of public biotechnology companies in May 2018

Read More

Venture capital and other investments in private biotech companies in May 2018

Read More

Milestone payments from corporate partners in May 2018

Read More

Nasdaq Stock Index 2018

Read More

Money raised by biotech: Jan. 1 – May 31, 2018

Read More

Money raised by biotech: 2018 vs. 2017

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More

Biotech industry has encountered headwinds slowing its progress over the past year

BOSTON – In 2012, the last time the BIO International Convention was held in Boston, Jim Greenwood, president and CEO of BIO, noted in a statement that "the overarching sentiment shared by the majority of attendees is a positive outlook for the future of our industry." His view was spot on because in the intervening five years the industry has been on a tear, with the Nasdaq Biotechnology Index recording a 155 percent jump in value. Fundraising has also been off the charts and business development has continued at a frenetic pace. Read More

Evolving from 'Promise to Performance' – celebrating 25 years

The evolution of the biotechnology industry has been mirrored in many respects by the growth of BIO's own meeting, which has expanded every year following the very first event hosted in Research Triangle Park, N.C., in 1993. BioWorld Insight takes a look back at those events and provides interesting statistics below on the evolution of the industry. Read More

Word on the street

Read More

Week in review

Read More

Week in Washington

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing